OBSOLETE: ATR-X-related syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:263355
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

ATR-X-related syndrome (Orphanet code 263355) is an obsolete disease classification that was previously used to group conditions caused by mutations in the ATRX gene (also known as the XNP gene or X-linked helicase 2 gene), located on the X chromosome. This entry has been retired and replaced by more specific diagnostic entities within the ATR-X spectrum. The primary condition now recognized is Alpha-Thalassemia X-linked Intellectual Disability (ATR-X) syndrome, characterized by severe intellectual disability, distinctive facial features (including a small nose with upturned nares, tented upper lip, and widely spaced eyes), genital anomalies in males (ranging from undescended testes to ambiguous genitalia), and alpha-thalassemia with hemoglobin H inclusions in red blood cells. The syndrome predominantly affects males, as it follows an X-linked recessive inheritance pattern. Additional features may include skeletal anomalies, feeding difficulties, and seizures. Because this Orphanet entry is obsolete, patients and clinicians should refer to the current active entries for ATR-X syndrome (OMIM #301040, Orphanet 847) for up-to-date clinical information, management guidelines, and genetic counseling. Treatment is supportive and symptomatic, with no curative therapy currently available. Management typically involves multidisciplinary care addressing developmental, neurological, urological, and hematological needs.

Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: ATR-X-related syndrome.

View clinical trials →

No actively recruiting trials found for OBSOLETE: ATR-X-related syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: ATR-X-related syndrome community →

No specialists are currently listed for OBSOLETE: ATR-X-related syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: ATR-X-related syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: ATR-X-related syndromeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: ATR-X-related syndrome.

Start the conversation →

Latest news about OBSOLETE: ATR-X-related syndrome

No recent news articles for OBSOLETE: ATR-X-related syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: ATR-X-related syndrome

What is OBSOLETE: ATR-X-related syndrome?

ATR-X-related syndrome (Orphanet code 263355) is an obsolete disease classification that was previously used to group conditions caused by mutations in the ATRX gene (also known as the XNP gene or X-linked helicase 2 gene), located on the X chromosome. This entry has been retired and replaced by more specific diagnostic entities within the ATR-X spectrum. The primary condition now recognized is Alpha-Thalassemia X-linked Intellectual Disability (ATR-X) syndrome, characterized by severe intellectual disability, distinctive facial features (including a small nose with upturned nares, tented uppe

How is OBSOLETE: ATR-X-related syndrome inherited?

OBSOLETE: ATR-X-related syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: ATR-X-related syndrome typically begin?

Typical onset of OBSOLETE: ATR-X-related syndrome is neonatal. Age of onset can vary across affected individuals.